402 related articles for article (PubMed ID: 23234514)
21. Impact of hematopoietic chimerism at day +14 on engraftment after unrelated donor umbilical cord blood transplantation for hematologic malignancies.
Moscardó F; Sanz J; Senent L; Cantero S; de la Rubia J; Montesinos P; Planelles D; Lorenzo I; Cervera J; Palau J; Sanz MA; Sanz GF
Haematologica; 2009 Jun; 94(6):827-32. PubMed ID: 19483157
[TBL] [Abstract][Full Text] [Related]
22. Ex vivo expansion of umbilical cord blood stem cells using different combinations of cytokines and stromal cells.
Madkaikar M; Ghosh K; Gupta M; Swaminathan S; Mohanty D
Acta Haematol; 2007; 118(3):153-9. PubMed ID: 17890847
[TBL] [Abstract][Full Text] [Related]
23. Multiple unit HLA-unmatched sex-mismatched umbilical cord blood transplantation for advanced hematological malignancy.
Lister J; Gryn JF; McQueen KL; Harris DT; Rossetti JM; Shadduck RK
Stem Cells Dev; 2007 Feb; 16(1):177-86. PubMed ID: 17348813
[TBL] [Abstract][Full Text] [Related]
24. CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies.
O'Donnell PV; Jones RJ; Vogelsang GB; Seber A; Ambinder RF; Flinn I; Miller C; Marcellus DC; Griffin C; Abrams R; Braine HG; Grever M; Hess AD; Piantadosi S; Noga SJ
Bone Marrow Transplant; 1998 Nov; 22(10):947-55. PubMed ID: 9849691
[TBL] [Abstract][Full Text] [Related]
25. Cotransplantation of ex vivo expanded and unexpanded cord blood units in immunodeficient mice using insulin growth factor binding protein-2-augmented mesenchymal cell cocultures.
Ong LM; Fan X; Chu PP; Gay FP; Bari S; Ang JM; Li Z; Chen J; Lim SK; Bunte RM; Hwang WY
Biol Blood Marrow Transplant; 2012 May; 18(5):674-82. PubMed ID: 22240732
[TBL] [Abstract][Full Text] [Related]
26. Pre-engraftment syndrome after unrelated donor umbilical cord blood transplantation in patients with hematologic malignancies.
Wang X; Liu H; Li L; Geng L; Ding K; Liu X; Tong J; Zhu W; Sun Z
Eur J Haematol; 2012 Jan; 88(1):39-45. PubMed ID: 21933279
[TBL] [Abstract][Full Text] [Related]
27. Ex vivo expanded cord blood cells provide rapid engraftment in fetal sheep but lack long-term engrafting potential.
McNiece IK; Almeida-Porada G; Shpall EJ; Zanjani E
Exp Hematol; 2002 Jun; 30(6):612-6. PubMed ID: 12063029
[TBL] [Abstract][Full Text] [Related]
28. Mesenchymal stromal cell supported umbilical cord blood ex vivo expansion enhances regulatory T cells and reduces graft versus host disease.
Fan X; Gay FP; Ong SY; Ang JM; Chu PP; Bari S; Lim TK; Hwang WY
Cytotherapy; 2013 May; 15(5):610-9. PubMed ID: 23419678
[TBL] [Abstract][Full Text] [Related]
29. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System.
Jaroscak J; Goltry K; Smith A; Waters-Pick B; Martin PL; Driscoll TA; Howrey R; Chao N; Douville J; Burhop S; Fu P; Kurtzberg J
Blood; 2003 Jun; 101(12):5061-7. PubMed ID: 12595310
[TBL] [Abstract][Full Text] [Related]
30. Platelet engraftment in patients with hematologic malignancies following unmanipulated haploidentical blood and marrow transplantation: effects of CD34+ cell dose and disease status.
Chang YJ; Xu LP; Liu DH; Liu KY; Han W; Chen YH; Yu-Wang ; Chen H; Wang JZ; Zhang XH; Zhao XY; Huang XJ
Biol Blood Marrow Transplant; 2009 May; 15(5):632-8. PubMed ID: 19361756
[TBL] [Abstract][Full Text] [Related]
31. Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults.
van Heeckeren WJ; Fanning LR; Meyerson HJ; Fu P; Lazarus HM; Cooper BW; Tse WW; Kindwall-Keller TL; Jaroscak J; Finney MR; Fox RM; Solchaga L; Forster M; Creger RJ; Laughlin MJ
Br J Haematol; 2007 Nov; 139(3):464-74. PubMed ID: 17910637
[TBL] [Abstract][Full Text] [Related]
32. Association between Nondominant Unit Total Nucleated Cell Dose and Engraftment in Myeloablative Double-Unit Cord Blood Transplantation.
Purtill D; Stevens CE; Lubin M; Ponce D; Hanash A; Giralt S; Scaradavou A; Young JW; Barker JN
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1981-4. PubMed ID: 26211983
[TBL] [Abstract][Full Text] [Related]
33. Cotransplantation of umbilical cord-derived mesenchymal stem cells promote hematopoietic engraftment in cord blood transplantation: a pilot study.
Wu KH; Sheu JN; Wu HP; Tsai C; Sieber M; Peng CT; Chao YH
Transplantation; 2013 Mar; 95(5):773-7. PubMed ID: 23274973
[TBL] [Abstract][Full Text] [Related]
34. Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation.
Thomson BG; Robertson KA; Gowan D; Heilman D; Broxmeyer HE; Emanuel D; Kotylo P; Brahmi Z; Smith FO
Blood; 2000 Oct; 96(8):2703-11. PubMed ID: 11023501
[TBL] [Abstract][Full Text] [Related]
35. Total colony-forming units are a strong, independent predictor of neutrophil and platelet engraftment after unrelated umbilical cord blood transplantation: a single-center analysis of 435 cord blood transplants.
Page KM; Zhang L; Mendizabal A; Wease S; Carter S; Gentry T; Balber AE; Kurtzberg J
Biol Blood Marrow Transplant; 2011 Sep; 17(9):1362-74. PubMed ID: 21277377
[TBL] [Abstract][Full Text] [Related]
36. [Umbilical cord blood cell transplantation from an unrelated donor: dual transplantation].
Bautista G; Regidor C; Gonzalo-Daganzo R; Cabrera JR
Methods Find Exp Clin Pharmacol; 2010 Dec; 32 Suppl A():47-51. PubMed ID: 21381288
[TBL] [Abstract][Full Text] [Related]
37. Phase II study of intrabone single unit cord blood transplantation for hematological malignancies.
Murata M; Maeda Y; Masuko M; Onishi Y; Endo T; Terakura S; Ishikawa Y; Iriyama C; Ushijima Y; Goto T; Fujii N; Tanimoto M; Kobayashi H; Shibasaki Y; Fukuhara N; Inamoto Y; Suzuki R; Kodera Y; Matsushita T; Kiyoi H; Naoe T; Nishida T
Cancer Sci; 2017 Aug; 108(8):1634-1639. PubMed ID: 28582607
[TBL] [Abstract][Full Text] [Related]
38. A prospective investigation of cell dose in single-unit umbilical cord blood transplantation for adults with high-risk hematologic malignancies.
Sobol U; Go A; Kliethermes S; Bufalino S; Rodriguez T; Smith S; Parthasarathy M; Stiff P
Bone Marrow Transplant; 2015 Dec; 50(12):1519-25. PubMed ID: 26367229
[TBL] [Abstract][Full Text] [Related]
39. [Clinical effect of umbilical cord blood transplantation in 37 pediatric patients with hematologic malignancies: a single-center experience].
Luan Z; Tang XF; Wu NH; Xu SX; Zhang B; Wang K; Du H
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jul; 16(7):714-9. PubMed ID: 25008879
[TBL] [Abstract][Full Text] [Related]
40. Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized study.
Horwitz ME; Stiff PJ; Cutler C; Brunstein C; Hanna R; Maziarz RT; Rezvani AR; Karris NA; McGuirk J; Valcarcel D; Schiller GJ; Lindemans CA; Hwang WYK; Koh LP; Keating A; Khaled Y; Hamerschlak N; Frankfurt O; Peled T; Segalovich I; Blackwell B; Wease S; Freedman LS; Galamidi-Cohen E; Sanz G
Blood; 2021 Oct; 138(16):1429-1440. PubMed ID: 34157093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
